Allogene Therapeutics
ALLO
$3.11
Share price
4.63%
Change (1 day)
-41.92%
Change (1 year)
Categories
Allogene Therapeutics (ALLO) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.13 B
According to Allogene Therapeutics 's latest financial reports the company's total liabilities are $0.13 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Allogene Therapeutics - Total liabilities on balance sheet (from 2018 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.15 B | 23.71% |
| 2021-12-31 | $0.12 B | -17.53% |
| 2020-12-31 | $0.14 B | 66.94% |
| 2019-12-31 | $88.77 M | 25.59% |
| 2018-12-31 | $70.69 M | 3534450% |
| 2017-12-31 | $0 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -78.62% | 🇺🇸 USA |